Sven Ullrich
Australian National University
H-index: 7
Oceania-Australia
Top articles of Sven Ullrich
Phage-encoded bismuth bicycles: Instant access to targeted bioactive peptides
bioRxiv
2024/4/10
A RaPID response to SARS-CoV-2
Israel Journal of Chemistry
2024/1/24
Sven Ullrich
H-Index: 1
Christoph Nitsche
H-Index: 21
Bicyclic peptides: Paving the road for therapeutics of the future
2024/3
Sven Ullrich
H-Index: 1
Christoph Nitsche
H-Index: 21
Probing ligand binding sites on large proteins by nuclear magnetic resonance spectroscopy of genetically encoded non-canonical amino acids
2023/7/11
Sven Ullrich
H-Index: 1
Christoph Nitsche
H-Index: 21
Thomas Huber
H-Index: 28
Gottfried Otting
H-Index: 38
Predicting antiviral resistance mutations in SARS-CoV-2 main protease with computational and experimental screening
Biochemistry
2022/11/3
Sven Ullrich
H-Index: 1
Christoph Nitsche
H-Index: 21
SARS-CoV-2 papain-like protease: Structure, function and inhibition
ChemBioChem
2022/8/22
Sven Ullrich
H-Index: 1
Christoph Nitsche
H-Index: 21
Site-selective generation of lanthanoid binding sites on proteins using 4-fluoro-2,6-dicyanopyridine
Magnetic Resonance
2022/9/13
Sven Ullrich
H-Index: 1
Thomas Huber
H-Index: 28
Christoph Nitsche
H-Index: 21
Gottfried Otting
H-Index: 38
Biocompatible and selective generation of bicyclic peptides
Angewandte Chemie International Edition
2022/10/24
Sven Ullrich
H-Index: 1
Christoph Nitsche
H-Index: 21
Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
Chemical science
2022
Sven Ullrich
H-Index: 1
Anthony J O'Donoghue
H-Index: 20
Gottfried Otting
H-Index: 38
Christoph Nitsche
H-Index: 21
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
Bioorganic & Medicinal Chemistry Letters
2022/4/15
Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
Bioorganic & Medicinal Chemistry Letters
2021/10/15
Sven Ullrich
H-Index: 1
Gottfried Otting
H-Index: 38
Colin Jackson
H-Index: 30
Christoph Nitsche
H-Index: 21
The SARS-CoV-2 main protease as drug target
2020/9/1
Sven Ullrich
H-Index: 1
Christoph Nitsche
H-Index: 21